Phase II study of docetaxel and estramustine in metastatic androgen-independent prostate cancer

By Guimaraes T.   Bento M.J.   Pinho T.   Guedes d.C.R.   Pinto F.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 159-159

Elsevier

Access to resources Recommend Favorite

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer

By Hussain M.   Smith D.C.   El-Rayes B.F.   Du W.   Vaishampayan U.   Fontana J.   Sakr W.   Wood D.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 774-780

Elsevier

Access to resources Recommend Favorite

Inhibition of prostate cancer growth by 9-aminocamptothecin and estramustine

By Naik H.   Lehr J.E.   Pienta K.J.  

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 508-511

Elsevier

Access to resources Recommend Favorite

Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: a randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate

By Janknegt R.A.   Boon T.A.   van de Beek C.   Grob P.  

Urology, Vol. 49, Iss. 3, 1997-05 ,pp. : 411-420

Elsevier

Access to resources Recommend Favorite

An active regimen of weekly paclitaxel and estramustine in metastatic androgen-independent prostate cancer

By Vaishampayan U.   Fontana J.   Du W.   Hussain M.  

Urology, Vol. 60, Iss. 6, 2002-12 ,pp. : 1050-1054

Elsevier

Access to resources Recommend Favorite